GB9016885D0 - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
GB9016885D0
GB9016885D0 GB909016885A GB9016885A GB9016885D0 GB 9016885 D0 GB9016885 D0 GB 9016885D0 GB 909016885 A GB909016885 A GB 909016885A GB 9016885 A GB9016885 A GB 9016885A GB 9016885 D0 GB9016885 D0 GB 9016885D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909016885A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to GB909016885A priority Critical patent/GB9016885D0/en
Publication of GB9016885D0 publication Critical patent/GB9016885D0/en
Priority to ITMI911953A priority patent/IT1251788B/it
Priority to IN627DE1991 priority patent/IN178446B/en
Priority to NZ238981A priority patent/NZ238981A/en
Priority to ZA915565A priority patent/ZA915565B/xx
Priority to BE9100685A priority patent/BE1004772A3/fr
Priority to MYPI91001315A priority patent/MY107500A/en
Priority to CH2179/91A priority patent/CH682715A5/fr
Priority to US07/734,493 priority patent/US5213812A/en
Priority to LU87982A priority patent/LU87982A1/fr
Priority to SE9102249A priority patent/SE505734C2/sv
Priority to NL9101306A priority patent/NL194637C/nl
Priority to ES09101785A priority patent/ES2046083B1/es
Priority to TNTNSN91067A priority patent/TNSN91067A1/fr
Priority to GR910100330A priority patent/GR1001512B/el
Priority to PT98497A priority patent/PT98497B/pt
Priority to AT0152591A priority patent/AT396425B/de
Priority to AU81466/91A priority patent/AU649696B2/en
Priority to KR1019910013237A priority patent/KR920003962A/ko
Priority to DK199101418A priority patent/DK175756B1/da
Priority to FI913646A priority patent/FI104149B/fi
Priority to IE270091A priority patent/IE65124B1/en
Priority to NO912986A priority patent/NO300158B1/no
Priority to GB9116472A priority patent/GB2246514B/en
Priority to MA22524A priority patent/MA22245A1/fr
Priority to JP3192950A priority patent/JP2818704B2/ja
Priority to DE4125542A priority patent/DE4125542A1/de
Priority to OA60055A priority patent/OA09387A/xx
Priority to CA002048270A priority patent/CA2048270C/en
Priority to FR9109773A priority patent/FR2665360B1/fr
Priority to SG25394A priority patent/SG25394G/en
Priority to AU59393/94A priority patent/AU666808B2/en
Priority to HK33294A priority patent/HK33294A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
GB909016885A 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions Pending GB9016885D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions
ITMI911953A IT1251788B (it) 1990-08-01 1991-07-15 Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute
IN627DE1991 IN178446B (https=) 1990-08-01 1991-07-15
NZ238981A NZ238981A (en) 1990-08-01 1991-07-16 Process for preparing sustained-release microcapsules
ZA915565A ZA915565B (en) 1990-08-01 1991-07-16 Preparation process of sustained release compositions and the compositions thus obtained
BE9100685A BE1004772A3 (fr) 1990-08-01 1991-07-19 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
CH2179/91A CH682715A5 (fr) 1990-08-01 1991-07-22 Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues.
MYPI91001315A MY107500A (en) 1990-08-01 1991-07-22 Preparation process of sustained release compositions and the compositions thus obtained
US07/734,493 US5213812A (en) 1990-08-01 1991-07-23 Preparation process of sustained release compositions and the compositions thus obtained
LU87982A LU87982A1 (fr) 1990-08-01 1991-07-25 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues
SE9102249A SE505734C2 (sv) 1990-08-01 1991-07-26 Framställningsförfarande för kompositioner med fördröjd frisättning och de så erhållna partiklarna
NL9101306A NL194637C (nl) 1990-08-01 1991-07-30 Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel.
ES09101785A ES2046083B1 (es) 1990-08-01 1991-07-30 Procedimiento para preparar composiciones de liberacion prolongada.
TNTNSN91067A TNSN91067A1 (fr) 1990-08-01 1991-07-30 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
GR910100330A GR1001512B (el) 1990-08-01 1991-07-30 Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως.
PT98497A PT98497B (pt) 1990-08-01 1991-07-30 Processo para a preparacao de particulas para a libertacao controlada de um ingrediente activo
GB9116472A GB2246514B (en) 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein
AT0152591A AT396425B (de) 1990-08-01 1991-07-31 Verfahren zur herstellung von zusammensetzungen, die stoffe anhaltend abgeben und so erhaltene zusammensetzungen
AU81466/91A AU649696B2 (en) 1990-08-01 1991-07-31 Preparation process of sustained release compositions and the compositions thus obtained
KR1019910013237A KR920003962A (ko) 1990-08-01 1991-07-31 서방형 제제 및 그의 제조 방법
DK199101418A DK175756B1 (da) 1990-08-01 1991-07-31 Fremgangsmåde til fremstilling af partikler med vedvarende frigivelse af aktiv ingrediens og partikler fremstillet herved
FI913646A FI104149B (fi) 1990-08-01 1991-07-31 Menetelmä valmistaa hitaasti vapauttavia seoksia
IE270091A IE65124B1 (en) 1990-08-01 1991-07-31 Sustained release pharmaceutical compositions and the preparation of particles for use therein
NO912986A NO300158B1 (no) 1990-08-01 1991-07-31 Fremgangsmåte ved fremstilling av partikler med kontinuerlig frigjöring
FR9109773A FR2665360B1 (fr) 1990-08-01 1991-08-01 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
JP3192950A JP2818704B2 (ja) 1990-08-01 1991-08-01 徐放性組成物およびその製造方法
MA22524A MA22245A1 (fr) 1990-08-01 1991-08-01 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues
DE4125542A DE4125542A1 (de) 1990-08-01 1991-08-01 Verfahren zur herstellung von zusammensetzungen mit verzoegerter freisetzung und so erhaltene zusammensetzungen
OA60055A OA09387A (fr) 1990-08-01 1991-08-01 "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".
CA002048270A CA2048270C (en) 1990-08-01 1991-08-01 Preparation process of sustained release compositions and the compositions thus obtained
SG25394A SG25394G (en) 1990-08-01 1994-02-21 Sustained release pharmaceutical compositions and the preparation of particles for use therein.
AU59393/94A AU666808B2 (en) 1990-08-01 1994-04-11 Sustained release compositions
HK33294A HK33294A (en) 1990-08-01 1994-04-14 Sustained release pharmaceutical compositions and the preparation of particles for use therein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9016885D0 true GB9016885D0 (en) 1990-09-12

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909016885A Pending GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Country Status (30)

Country Link
US (1) US5213812A (https=)
JP (1) JP2818704B2 (https=)
KR (1) KR920003962A (https=)
AT (1) AT396425B (https=)
AU (2) AU649696B2 (https=)
BE (1) BE1004772A3 (https=)
CA (1) CA2048270C (https=)
CH (1) CH682715A5 (https=)
DE (1) DE4125542A1 (https=)
DK (1) DK175756B1 (https=)
ES (1) ES2046083B1 (https=)
FI (1) FI104149B (https=)
FR (1) FR2665360B1 (https=)
GB (1) GB9016885D0 (https=)
GR (1) GR1001512B (https=)
HK (1) HK33294A (https=)
IE (1) IE65124B1 (https=)
IN (1) IN178446B (https=)
IT (1) IT1251788B (https=)
LU (1) LU87982A1 (https=)
MA (1) MA22245A1 (https=)
MY (1) MY107500A (https=)
NL (1) NL194637C (https=)
NO (1) NO300158B1 (https=)
NZ (1) NZ238981A (https=)
OA (1) OA09387A (https=)
PT (1) PT98497B (https=)
SE (1) SE505734C2 (https=)
TN (1) TNSN91067A1 (https=)
ZA (1) ZA915565B (https=)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
DE69529054T2 (de) * 1994-02-28 2003-08-21 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
DK1140026T3 (da) * 1998-12-16 2006-01-02 Aventis Pharma Inc Serotoninreceptorantagonist indkapslet i biologisk nedbrydelig polymer og fremgangsmåde til fremstilling af samme
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1335661B1 (en) 2000-10-27 2009-05-06 Baxter Healthcare S.A. Production of microspheres
ATE395042T1 (de) * 2001-08-16 2008-05-15 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
RU2426590C2 (ru) * 2003-07-18 2011-08-20 Бакстер Интернэшнл Инк. Способы изготовления, применение и композиции небольших сферических частиц, приготовленных регулируемым фазовым разделением
US20050048127A1 (en) * 2003-07-22 2005-03-03 Larry Brown Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8333995B2 (en) * 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
JP2008506700A (ja) * 2004-07-13 2008-03-06 アルテアーナノ，インコーポレーテッド 薬物の制御された放出のためのセラミック構造体
JP2008506699A (ja) * 2004-07-13 2008-03-06 アルテアーナノ，インコーポレーテッド 薬物転用防止用セラミック構造体
US20070243234A1 (en) * 2004-10-29 2007-10-18 Peter Gabriele Microscopic Tagging System for Security Identification
AU2006241145B2 (en) * 2005-04-27 2011-04-28 Baxter Healthcare S. A. Surface-modified microparticles and methods of forming and using the same
JP2009505824A (ja) * 2005-08-23 2009-02-12 アルテアナノ インコーポレイテッド 高度な光触媒のリンドープアナターゼＴｉＯ２組成物及びその製造方法
US20080008843A1 (en) * 2006-03-02 2008-01-10 Fred Ratel Method for Production of Metal Oxide Coatings
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
WO2007103820A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured indium-doped iron oxide
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
EP2068845A2 (en) * 2006-10-06 2009-06-17 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
JP2010505883A (ja) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
AU2009237577B2 (en) 2008-04-18 2014-06-05 Baxter Healthcare Sa Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010037021A2 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CA2762653A1 (en) * 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
WO2011038053A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
AU2011258165B2 (en) 2010-05-26 2016-11-17 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
EP3149049B1 (en) 2014-05-27 2022-10-26 The University Of Queensland Il-22 for use in treating metabolic disorders
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (https=) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
MA22245A1 (fr) 1992-04-01
FR2665360B1 (fr) 1995-02-10
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
JPH05178740A (ja) 1993-07-20
PT98497B (pt) 1997-10-31
MY107500A (en) 1995-12-30
TNSN91067A1 (fr) 1992-10-25
NL9101306A (nl) 1992-03-02
LU87982A1 (fr) 1992-04-15
ITMI911953A1 (it) 1993-01-15
GR910100330A (en) 1992-08-31
BE1004772A3 (fr) 1993-01-26
AU666808B2 (en) 1996-02-22
US5213812A (en) 1993-05-25
FI913646A0 (fi) 1991-07-31
ES2046083B1 (es) 1994-08-01
IE912700A1 (en) 1992-02-12
CA2048270A1 (en) 1992-02-02
DK175756B1 (da) 2005-02-14
HK33294A (en) 1994-04-22
NZ238981A (en) 1992-11-25
IT1251788B (it) 1995-05-26
IE65124B1 (en) 1995-10-04
ES2046083A1 (es) 1994-01-16
KR920003962A (ko) 1992-03-27
ZA915565B (en) 1992-04-29
FI104149B1 (fi) 1999-11-30
FI104149B (fi) 1999-11-30
AU649696B2 (en) 1994-06-02
ITMI911953A0 (it) 1991-07-15
DK141891A (da) 1992-02-02
AU5939394A (en) 1994-06-02
SE9102249D0 (sv) 1991-07-26
JP2818704B2 (ja) 1998-10-30
AU8146691A (en) 1992-02-06
FI913646L (fi) 1992-02-02
IN178446B (https=) 1997-05-03
DK141891D0 (da) 1991-07-31
SE505734C2 (sv) 1997-10-06
SE9102249L (sv) 1992-02-02
NL194637C (nl) 2002-10-04
GR1001512B (el) 1994-02-28
NO912986D0 (no) 1991-07-31
CH682715A5 (fr) 1993-11-15
CA2048270C (en) 1997-02-25
PT98497A (pt) 1992-06-30
FR2665360A1 (fr) 1992-02-07
DE4125542A1 (de) 1992-02-06
ATA152591A (de) 1993-01-15
OA09387A (fr) 1992-09-15
AT396425B (de) 1993-09-27
NO300158B1 (no) 1997-04-21

Similar Documents

Publication Publication Date Title
GB9016885D0 (en) Sustained release pharmaceutical compositions
GB2230185B (en) Sustained release pharmaceutical compositions
GB2262445B (en) Controlled release pharmaceutical compositions
GB2253348B (en) Sustained release compositions
ZA904925B (en) Sustained release pharmaceutical compositions
GB9115893D0 (en) Pharmaceutical compositions
GB9111314D0 (en) Pharmaceutical compositions
GB9023023D0 (en) Pharmaceutical compositions
GB9115693D0 (en) Solid pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
ZA917596B (en) Pharmaceutical compositions
GB9115156D0 (en) Pharmaceutical compositions
ZA915555B (en) Continuous release pharmaceutical compositions
GB9018415D0 (en) Continuous release pharmaceutical compositions
GB9018418D0 (en) Continuous release pharmaceutical compositions
GB9018414D0 (en) Continuous release pharmaceutical compositions
GB9019845D0 (en) Continuous release pharmaceutical compositions
GB9025284D0 (en) Continuous release pharmaceutical compositions
GB9018416D0 (en) Continuous release pharmaceutical compositions
GB9018417D0 (en) Continuous release pharmaceutical compositions
GB9015418D0 (en) Pharmaceutical compositions
GB9002442D0 (en) Sustained release compositions
GB9017202D0 (en) Pharmaceutical compositions
GB9026882D0 (en) Pharmaceutical compositions